NICE adds further details on how the UK will pay more for drugsnews2025-12-05T16:29:30+00:00December 5th, 2025|Endpoints News|
Denali drug hold; Intercept layoffs; Capital raises for Immatics, Capricor and Protaranews2025-12-05T16:05:30+00:00December 5th, 2025|Endpoints News|
Rapport shares updated results from Phase 2 study of seizure drugnews2025-12-05T16:02:46+00:00December 5th, 2025|Endpoints News|
Biopharma sentiment hit a turning point in Octobernews2025-12-05T15:51:32+00:00December 5th, 2025|Endpoints News|
OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolionews2025-12-05T15:27:01+00:00December 5th, 2025|Endpoints News|
German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozymenews2025-12-05T12:01:34+00:00December 5th, 2025|Endpoints News|
Ex-Intercept CEO to take over at Altimmune; Carolyn Bertozzi leaves Alnylam’s boardnews2025-12-05T12:00:12+00:00December 5th, 2025|Endpoints News|
Praxis stops pivotal trial of rare epilepsy drug early for efficacynews2025-12-05T11:10:58+00:00December 5th, 2025|Endpoints News|
A year of scrutiny for health insurersnews2025-12-04T20:56:28+00:00December 4th, 2025|Endpoints News|
ACIP delays vote on hepatitis B birth dose to Fridaynews2025-12-04T20:51:19+00:00December 4th, 2025|Endpoints News|
